Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndrome.
Tsujimoto Y, Yamamoto N, Bando H, Yamamoto M, Ohmachi Y, Motomura Y, Oi-Yo Y, Sasaki Y, Suzuki M, Urai S, Takahashi M, Iguchi G, Ogawa W, Fukuoka H.
Tsujimoto Y, et al. Among authors: takahashi m.
Front Endocrinol (Lausanne). 2024 Dec 23;15:1511155. doi: 10.3389/fendo.2024.1511155. eCollection 2024.
Front Endocrinol (Lausanne). 2024.
PMID: 39764253
Free PMC article.